Stay updated on Tresiba Long-term Use Post-marketing Clinical Trial

Sign up to get notified when there's something new on the Tresiba Long-term Use Post-marketing Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tresiba Long-term Use Post-marketing Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T21:53:31.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety and effectiveness of long-term treatment with Tresiba® in patients with diabetes mellitus requiring insulin therapy under normal clinical practice conditions.
    Difference
    0.2%
    Check dated 2024-06-06T14:29:58.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study. It now specifies that patients with diabetes mellitus requiring insulin therapy, who have not previously been treated with Tresiba®, are eligible, while those who have been on Tresiba® therapy or participated in this PMS are excluded.
    Difference
    13%
    Check dated 2024-05-22T21:02:16.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:13:52.000Z thumbnail image

Stay in the know with updates to Tresiba Long-term Use Post-marketing Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tresiba Long-term Use Post-marketing Clinical Trial page.